SC
TMO icon

Sapient Capital’s Thermo Fisher Scientific TMO Stock Holding History

Sapient Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$316K Sell
468
-417
-47% -$248K ﹤0.01% 316
2026
Q2 		$444K Buy
885
+91
+11% +$43.7K 0.01% 281
2026
Q1 		$391K Sell
794
-1,214
-60% -$659K 0.01% 310
2025
Q4 		$1.17M Buy
2,008
+712
+55% +$403K 0.02% 190
2025
Q3 		$599K Sell
1,296
-352
-21% -$164K 0.01% 243
2025
Q2 		$669K Sell
1,648
-32
-2% -$13.4K 0.01% 225
2025
Q1 		$837K Sell
1,680
-35
-2% -$19K 0.02% 204
2024
Q4 		$893K Buy
1,715
+453
+36% +$249K 0.02% 193
2024
Q3 		$781K Sell
1,262
-6
-0.5% -$3.55K 0.02% 213
2024
Q2 		$702K Buy
1,268
+14
+1% +$8.02K 0.01% 201
2024
Q1 		$729K Sell
1,254
-26
-2% -$14.6K 0.02% 206
2023
Q4 		$680K Buy
+1,280
New +$620K 0.02% 207

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Sapient Capital's TMO Position: Q3 2026 in Review

Sapient Capital reduced its Thermo Fisher Scientific (TMO) stake by 47% in Q3 2026, selling an estimated $248K and leaving 468 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

Sapient Capital first reported a position in TMO in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.17M in Q4 2025. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Sapient Capital held 468 shares of Thermo Fisher Scientific worth $316K as of Q3 2026.
  • Sapient Capital sold 417 Thermo Fisher Scientific shares in Q3 2026, an estimated $248K.
  • Thermo Fisher Scientific made up ﹤0.01% of Sapient Capital's portfolio in Q3 2026, its #316 holding.
  • Sapient Capital first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 12 quarters since.
  • Sapient Capital's Thermo Fisher Scientific position peaked at $1.17M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.